Boltwood Capital Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $973K | Buy |
9,407
+622
| +7% | +$55.5K | 0.22% | 98 |
|
|
2026
Q1 | $631K | Sell |
8,785
-10
| -0.1% | -$770 | 0.16% | 114 |
|
|
2025
Q4 | $698K | Buy |
8,795
+65
| +0.7% | +$5.12K | 0.18% | 106 |
|
|
2025
Q3 | $658K | Buy |
8,730
+120
| +1% | +$8.22K | 0.18% | 112 |
|
|
2025
Q2 | $594K | Sell |
8,610
-60
| -0.7% | -$3.93K | 0.17% | 111 |
|
|
2025
Q1 | $587K | Sell |
8,670
-530
| -6% | -$31.7K | 0.18% | 108 |
|
|
2024
Q4 | $413K | Buy |
9,200
+93
| +1% | +$5.22K | 0.13% | 129 |
|
|
2024
Q3 | $573K | Buy |
9,107
+88
| +1% | +$5.13K | 0.17% | 104 |
|
|
2024
Q2 | $533K | Sell |
9,019
-3,113
| -26% | -$195K | 0.17% | 110 |
|
|
2024
Q1 | $968K | Sell |
12,132
-35
| -0.3% | -$2.67K | 0.3% | 80 |
|
|
2023
Q4 | $961K | Sell |
12,167
-955
| -7% | -$68K | 0.32% | 78 |
|
|
2023
Q3 | $916K | Buy |
13,122
+10
| +0.1% | +$709 | 0.34% | 73 |
|
|
2023
Q2 | $906K | Sell |
13,112
-25
| -0.2% | -$1.78K | 0.33% | 77 |
|
|
2023
Q1 | $976K | Buy |
13,137
+390
| +3% | +$32.7K | 0.36% | 72 |
|
|
2022
Q4 | $1.19M | Sell |
12,747
-255
| -2% | -$24.6K | 0.48% | 57 |
|
|
2022
Q3 | $1.24M | Sell |
13,002
-40
| -0.3% | -$3.96K | 0.57% | 50 |
|
|
2022
Q2 | $1.21M | Sell |
13,042
-35
| -0.3% | -$3.42K | 0.52% | 57 |
|
|
2022
Q1 | $1.32M | Sell |
13,077
-445
| -3% | -$46.7K | 0.51% | 60 |
|
|
2021
Q4 | $1.4M | Sell |
13,522
-60
| -0.4% | -$5.54K | 0.52% | 62 |
|
|
2021
Q3 | $1.15M | Buy |
13,582
+15
| +0.1% | +$1.26K | 0.46% | 68 |
|
|
2021
Q2 | $1.13M | Sell |
13,567
-148
| -1% | -$12.1K | 0.47% | 65 |
|
|
2021
Q1 | $1.03M | Sell |
13,715
-160
| -1% | -$11.7K | 0.46% | 68 |
|
|
2020
Q4 | $948K | Buy |
13,875
+275
| +2% | +$17.9K | 0.46% | 69 |
|
|
2020
Q3 | $794K | Buy |
13,600
+120
| +0.9% | +$7.47K | 0.44% | 75 |
|
|
2020
Q2 | $876K | Buy |
13,480
+75
| +0.6% | +$4.72K | 0.53% | 60 |
|
|
2020
Q1 | $795K | Sell |
13,405
-410
| -3% | -$27.4K | 0.56% | 61 |
|
|
2019
Q4 | $1.03M | Buy |
13,815
+970
| +8% | +$68.1K | 0.58% | 58 |
|
|
2019
Q3 | $810K | Buy |
12,845
+825
| +7% | +$48.9K | 0.51% | 70 |
|
|
2019
Q2 | $655K | Buy |
12,020
+2,940
| +32% | +$158K | 0.42% | 79 |
|
|
2019
Q1 | $490K | Buy |
+9,080
| New | +$560K | 0.32% | 90 |
|
|
2017
Q4 | – | Sell |
-8,565
| Closed | -$696K | – | 123 |
|
|
2017
Q3 | $696K | Sell |
8,565
-10
| -0.1% | -$791 | 0.45% | 70 |
|
|
2017
Q2 | $689K | Sell |
8,575
-100
| -1% | -$7.9K | 0.47% | 72 |
|
|
2017
Q1 | $680K | Buy |
8,675
+975
| +13% | +$77.8K | 0.48% | 70 |
|
|
2016
Q4 | $607K | Buy |
+7,700
| New | +$623K | 0.46% | 73 |
|
Other funds holding CVS
LMFP
CF
HCM
FWIA
CGH
Boltwood Capital Management's CVS Position: Q2 2026 in Review
Boltwood Capital Management increased its CVS Health (CVS) stake by 7.1% in Q2 2026, buying an estimated $55.5K and bringing the position to 9,407 shares worth $973K. The position accounts for 0.22% of the portfolio, ranked #98.
Boltwood Capital Management first reported a position in CVS in Q4 2016 and has held it in 34 quarters since. The position peaked at $1.4M in Q4 2021. 515 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Boltwood Capital Management held 9,407 shares of CVS Health worth $973K as of Q2 2026.
- Boltwood Capital Management bought 622 CVS Health shares in Q2 2026, an estimated $55.5K.
- CVS Health made up 0.22% of Boltwood Capital Management's portfolio in Q2 2026, its #98 holding.
- Boltwood Capital Management first reported a position in CVS Health in Q4 2016 and has held it in 34 quarters since.
- Boltwood Capital Management's CVS Health position peaked at $1.4M in Q4 2021.
- 515 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Boltwood Capital Management's 13F filing for Q2 2026, filed 6 Jul 2026.